AKUMS

Akums Drugs & Pharmaceuticals Share Price

 

 

Invest in Akums Drugs & Pharmaceuticals with 3.28X leverage

Invest with MTF
Akums Drugs & Pharmaceuticals live price: ₹500.6. It opened at ₹480 vs previous close ₹480; intraday high/low: ₹503/₹480. The 50 & 200 DMA stand at ₹462.12/₹491.62.

Akums Drugs & Pharmaceuticals Performance

  • Low
  • ₹480
  • High
  • ₹503
  • 52 Week Low
  • ₹405
  • 52 Week High
  • ₹623
  • Open Price₹480
  • Previous Close₹480
  • Volume265,575
  • 50 DMA₹462.12
  • 100 DMA₹460.51
  • 200 DMA₹491.62

Investment Returns

  • Over 1 Month + 7.15%
  • Over 3 Month + 18.74%
  • Over 6 Month + 8.3%
  • Over 1 Year -0.6%

Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 24.8
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 7,879
  • P/B Ratio
  • 2.4
  • Average True Range
  • 17.02
  • EPS
  • 20.62
  • Dividend Yield
  • 0
  • MACD Signal
  • 8.78
  • RSI
  • 63.43
  • MFI
  • 52.67

Akums Drugs & Pharmaceuticals Financials

Akums Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹500.60
+ 21 (4.38%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹475.38
  • 50 Day
  • ₹462.12
  • 100 Day
  • ₹460.51
  • 200 Day
  • ₹491.62

Resistance and Support

494.4 Pivot Speed
  • R3 532.60
  • R2 517.80
  • R1 509.20
  • S1 485.80
  • S2 471.00
  • S3 462.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Akums Drugs & Pharmaceuticals Ltd. is India’s leading contract manufacturing company, producing a wide range of pharmaceutical and nutraceutical products. It provides end-to-end solutions, including formulation development, manufacturing, and packaging for domestic and global clients.

Akums Drugs And Pharmaceuticals Ltd has an operating revenue of Rs. 4,256.70 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 8% is okay, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 76 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 89 indicates it belongs to a poor industry group of Medical-Products and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-08 Quarterly Results
2025-05-26 Audited Results
2025-02-06 Quarterly Results

Akums Drugs & Pharmaceuticals F&O

Akums Drugs & Pharmaceuticals Shareholding Pattern

75.26%
11.23%
0.65%
1.14%
5.51%
6.21%

About Akums Drugs & Pharmaceuticals

  • NSE Symbol
  • AKUMS
  • BSE Symbol
  • 544222
  • Managing Director
  • Mr. Sanjeev Jain
  • ISIN
  • INE09XN01023

Similar Stocks to Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals FAQs

Akums Drugs & Pharmaceuticals share price is ₹500 As on 11 March, 2026 | 06:00

The Market Cap of Akums Drugs & Pharmaceuticals is ₹7879.1 Cr As on 11 March, 2026 | 06:00

The P/E ratio of Akums Drugs & Pharmaceuticals is 24.8 As on 11 March, 2026 | 06:00

The PB ratio of Akums Drugs & Pharmaceuticals is 2.4 As on 11 March, 2026 | 06:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23